基于冷冻精子和胚胎运输的新型跨国新鲜卵母细胞捐赠(TOD)项目
这项回顾性队列研究纳入2015年12月至2017年7月接受治疗的630例不孕女性,在西班牙与意大利两家IVF诊所间运输玻璃化冻融胚胎并移植。共创建2617枚胚胎,复苏存活率98.5%,首次移植活产率30.6%,第二次移植活产率30%,观察期末累积活产率39.3%。作者认为该跨国卵母细胞捐赠项目高效可靠,可作为部分国家解决供者不足的一线策略。
要点
- 630例患者共创建2617枚胚胎,复苏存活率98.5%。
- 首次移植活产率30.6%,第二次移植活产率30%,累积活产率39.3%。
- 作者认为该跨国新鲜卵母细胞捐赠项目高效,可作为距离及跨国卵母细胞捐赠项目的一线策略。
核心结论
- 跨国卵母细胞捐赠项目高效可靠,可能作为部分国家克服供者不足的一线策略。
- 作者认为本研究的活产率可接受,且似乎高于玻璃化卵母细胞所报告的水平。
- 作者提出TOD项目可能具有优于运输玻璃化卵母细胞的优势,并可能作为距离及跨国卵母细胞捐赠项目的一线策略。
研究设计与样本
- 回顾性队列研究,纳入2015年12月至2017年7月接受治疗的630例不孕女性。
- 在西班牙与意大利两家IVF诊所之间进行选择性玻璃化冻融胚胎运输与胚胎移植。
主要发现
- 630例患者共创建2617枚胚胎,复苏后存活率为98.5%。
- 首次胚胎移植后活产率为30.6%。
- 476例患者(75.5%)移植卵裂期胚胎(第2或3天),活产率为29.2%。
- 154例患者(24.5%)有可用的玻璃化囊胚,活产率为35%。
- 首次冻融胚胎移植未妊娠的患者中,92.5%至少有一枚冷冻胚胎可供后续操作;213例患者进行了第二次冻融胚胎移植,第二次移植活产率为30%;观察期末累积活产率为39.3%。
临床怎么用
- 作者认为TOD项目高效,可能作为距离及跨国卵母细胞捐赠项目的一线策略。
- 作者认为该项目类似新鲜卵母细胞捐赠项目,通过分配灵活数量的卵母细胞为受者提供个性化医疗,同时保留冷冻辅助生殖技术项目的调度灵活性。
局限性
- 研究设计为回顾性。
- 原文指出,若与玻璃化卵母细胞捐赠周期及随后的新鲜胚胎移植进行直接比较,将能比较该策略与当前基于玻璃化配子的标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the clinical efficacy of an oocyte donation program based on the transportation of frozen semen and embryos between two countries? SUMMARY ANSWER: The transnational oocyte donation program is efficient and reliable and it could provide a first-line strategy to overcome the lack of donors in some countries. WHAT IS KNOWN ALREADY: While there is increasing need for donated oocytes, in many countries the availability of donors is still insufficient to cover the therapeutic demands, and patients are referred abroad for treatment. Since embryo cryopreservation is reliable and efficient, we propose a strategy based on frozen embryos instead of frozen oocytes to satisfy the increasing demand for cross border oocyte donation. STUDY DESIGN, SIZE, DURATION: This is a retrospective cohort study including 630 patients treated from December 2015 to July 2017. PARTICIPANTS/MATERIALS, SETTING, METHODS: Infertile women were treated with elective vitrified-thawed embryo shipping and embryo transfer (ET) between two IVF clinics, one in Spain and one in Italy. MAIN RESULTS AND THE ROLE OF CHANCE: A total of 2617 embryos were created for the 630 patients and the survival rate after warming was 98.5%. After the first ET the live birth rate (LBR) was 30.6%. In 476 patients (75.5%), embryos were transferred at the cleavage stage (Day 2 or 3) and the LBR was 29.2%. Vitrified blastocysts were available for 154 patients (24.5%) and the LBR was 35%. Among patients who did not achieve a pregnancy after the first frozen ET (FET), 92.5% had at least one frozen embryo for successive procedures. 213 patients underwent a second FET. The LBR at the second FET was 30%. The cumulative LBR at the end of the observation period was 39.3%. LIMITATIONS, REASONS FOR CAUTION: The study design was retrospective. A direct comparison with vitrified oocyte donors cycle and subsequent fresh ET would have permitted to compare this strategy versus the current standard based on vitrified gametes. WIDER IMPLICATIONS OF THE FINDINGS: The LBR found in our study is more than acceptable and seems to be higher than what reported with vitrified oocytes. The transnational fresh oocyte donation program may have several advantages over the shipment of vitrified oocytes: similarly to the fresh oocyte donation program it allows for personalized care in oocyte recipient, which is provided by assigning a flexible number of oocytes, and at the same time it maintains the benefit of a frozen ART program permitting scheduling flexibility. The TOD program is efficient and may be proposed as a first-line strategy for distance and inter-countries oocyte donation programs. STUDY FUNDING, COMPETING INTEREST(S): None. TRIAL REGISTRATION NUMBER: NA.
引用
- La Marca A, Dal Canto M, Buccheri M, et al. A novel transnational fresh oocyte donation (TOD) program based on transport of frozen sperm and embryos. Hum Reprod. 2019. PMID: 30520998. doi:10.1093/humrep/dey331
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。